In the original article by Ling et al., entitled “LncRNA NEAT1 Promotes Deterioration of
Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis”
[Cell Physiol Biochem 2018;48(2):540-555, DOI: 10.1159/000491811], the texts in the results as
well as Fig. 1 contain an error (the number of non-cancerous samples should be 180 instead of
174), Fig. 3E and Fig. 4C contain misplaced figures, and the name of the cell line “HepB3“ should
be “Hep3B“ (in text, figures and figure legends).
The corrected sentences are shown below, together with their page numbers, as well as the
corrected Fig. 1, Fig. 2, Fig. 3 and Fig. 4.
The authors confirm that all of the results and conclusions of the article remain unchanged, as
well as the figure legend.
The authors sincerely apologize for the mistakes.
On page 542: “Two human HCC cell lines, HepG2 and Hep3B, were obtained from the American
Type Culture Collection (Manassas, VA) and cultured as described previously [24].”
On page 543: “In this study, NEAT1 siRNA effectively decreased NEAT1 expression in HepG2 and
Hep3B cells.”
On page 544: “The effect of NEAT1 on cell migration and invasion was examined in Hep3B cells
using wound-healing and Transwell assays. NEAT1 siRNA caused signifcant reductions in the
wound healing rate and invasiveness of the Hep3B cells compared with the blank control (Fig. 4).”
On page 544: “A total of four records containing 574 HCC samples and 180 non-cancerous
specimens were included in our study.”
On page 551: “In the present study, we detected the effects of NEAT1 on proliferation,
apoptosis, migration, and invasion of HCC cells by transfecting NEAT1 siRNA into Hep3B
and/or HepG2 cells.”